SPARC and cancer: In SW480 cells, IWR1 treatment resulted in the translocation of Tet2CD from the nucleus to the cytosol, impaired TET2-induced DNA demethylation, facilitated the growth of cancer cells and decreased the expression of RORA and SPARC (Fig. 6A, B and Supplementary Figure S6A-C).